Latest News & Features
Americas
The 2016 BIO International Convention kicked off in style Monday night with an evening of scientific discovery at the Exploratorium. 7 June 2016
Americas
Pharmaceutical company AstraZeneca has agreed a licensing deal with German drug maker Grünenthal centring on gout treatment drug Zurampic. 6 June 2016
article
More than 15,000 life sciences industry professionals will arrive in San Francisco for the 2016 BIO International Convention from June 6 to 9. LSIPR highlights some of the most interesting sessions 6 June 2016
Americas
If you can find the time between attending sessions and networking, making the most of the local area is an essential part of the 2016 BIO International Convention. LSIPR offers five tips for things to see and do in San Francisco. 6 June 2016
Americas
President Barack Obama has praised scientists and the technology industry at the honorary ceremony for scientists at the White House. 2 June 2016
Big Pharma
National Health Service England has been criticised after announcing its decision that it will not be providing the HIV treatment Truvada, which enables pre-exposure prophylaxis. 2 June 2016
Americas
Law firm Fox Rothschild has hired Patrick Birde, Deborah Somerville and Christopher Glynn as partners in the firm’s intellectual property practice. 2 June 2016
Americas
Jazz Pharmaceuticals, based in Ireland, will buy US company Celator Pharmaceuticals for $1.5 billion in cash. 1 June 2016
Americas
The US Supreme Court has refused to review Cubist Pharmaceuticals’ infringement case over the antibiotic drug Cubicin. 1 June 2016
Americas
Thermo Fisher Scientific has announced that it will buy FEI, an electron microscopy company, for $4.2 billion. 31 May 2016